Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Dose Response Study of Transdermal Human Insulin in Patients

NCT: NCT05159453 · NOT_YET_RECRUITING

NCT IDNCT05159453
StatusNOT_YET_RECRUITING
Start Date2027-09-02
Completion2027-12-15
SponsorTransdermal Delivery Solutions Corp (INDUSTRY)
First posted
Last updated

Brief Summary

A 21-Day open label study of transdermally delivered human insulin in Type 2 Diabetics as measured by response of down modulation of glucose after dosing of Insulin as compared to historic patient response to injected insulins.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑